The National Heart, Lung, and Blood Institute (NHLBI) intends to award a non-competitive contract to Ozgene in Bentley, WA, Australia. The purpose is to acquire mouse models carrying the human ß-globin gene for evaluating a specific fusion protein and compounds related to sickle cell disease and ß-thalassemia.